Highlights and Announcements



Dr. Michael Oshinsky, Director of the NINDS Office of Preclinical Pain Research, is the featured guest on the July 27 episode of the Spotlight on Migraine podcast, “Understanding and Managing Migraine in Kids and Teens.”

Genome editing, which enables precise modifications to DNA, has the potential to lead to breakthrough treatments for diseases caused by genetic changes.



NINDS is mourning the loss of Dr. Ann-Marie Broome, a program director in the Division of Translational Research. During her time at NINDS, Ann-Marie played a key role in creating two large and innovative initiatives: the Blueprint Biologics Program and the URGenT Network.

Effective April 13, 2021, Andrew B. Singleton, Ph.D., is the director of a new NIH intramural laboratory, the Center for Alzheimer’s and Related Dementias (CARD).


NIH has announced the selection of Andrea Beckel-Mitchener, Ph.D., of the National Institute of Mental Health (NIMH), as deputy director of the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative.